PROZPRA DSR (Capsule)

PROZPRA DSR is a high-potency capsule formulation containing Pantoprazole Sodium 40 mg + Domperidone 30 mg.

Composition: Pantoprazole Sodium 40 mg + Domperidone 30 mg
Dosage Form: Capsule

Clinical Pharmacology

Pantoprazole suppresses gastric acid secretion. Domperidone enhances gastrointestinal motility and provides antiemetic effects.

Indications & Usage

• GERD with associated dyspeptic symptoms
• Acid-related dyspepsia
• GERD with nausea/regurgitation where prokinetic therapy is clinically appropriate
• Upper gastrointestinal disorders requiring combined acid suppression and prokinetic therapy

Contraindications

Domperidone-related cardiac, gastrointestinal obstruction and hypersensitivity contraindications apply.

Warnings & Precautions

Use the lowest effective domperidone dose for the shortest duration. Assess cardiac risk factors before prescribing.

Drug Interactions

QT-prolonging drugs and potent CYP3A4 inhibitors.

Pregnancy & Lactation

Use only when clinically justified.

Dosage & Administration

As directed by the physician, generally before meals.

Adverse Reactions

Headache, diarrhea, nausea, abdominal discomfort, dry mouth and potential cardiac rhythm disturbances.

Therapeutic Focus: PPI + Prokinetic | Primary Specialty: Gastroenterology